Biotech

All Articles

ArsenalBio raises $325M, rotates out of previous lead asset

.Arsenal Biosciences is carrying on up. The cell therapy company has actually added $325 thousand in...

Lilly- supported weight reduction biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis make use of medicine flunks phase 2b, steering Indivior to re-think $100M option

.Aelis Farma's chances of securing an easy, good selection on a $100 million possibility remittance ...

ProKidney standstills period 3 trial not needed to have for tissue treatment permission

.ProKidney has actually ceased some of a set of phase 3 trials for its tissue therapy for kidney ail...

Vaxcyte rises on 'spectacular' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals named "spectacular" period 1/2 records for its own 31-valent pn...

Recursion's mind ailment test shows insufficient documentation of efficacy

.Recursion has discovered through a very early test of its own tech-enabled strategy to drug explora...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Phone it an instance of great chemical make up: Acepodia, a biotech based on Nobel Champion scienti...

Praxis epilepsy medication reduces seizures in period 2 litigation

.Practice Accuracy Medicines has scored one more midphase gain in epilepsy this year, with its own s...

Three officers surrender as Dyne blog posts blended information for DMD prospect

.After getting away from a medical hold numerous years back, Dyne Therapy has actually disclosed bra...

Arrowhead fires off stage 3 information in uncommon metabolic disease before market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in advance of a potential face-off with Ionis, ...